You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sclc

Showing 51 - 75 of 720
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Small Cell Lung Carcinoma Trial in Milano (Cyclic, 5-day calorie restriction, Atezolizumab)

Not yet recruiting
  • Small Cell Lung Carcinoma
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Jan 19, 2023

Small Cell Lung Cancer, Lung Cancer Trial in Switzerland (Durvalumab, carboplatin, etoposide)

Recruiting
  • Small Cell Lung Cancer
  • Lung Cancer
  • Aarau, Switzerland
  • +13 more
Aug 12, 2022

Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • (no location specified)
Feb 21, 2023

Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Topotecan)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • (no location specified)
Aug 7, 2023

ctDNA in Evaluation of Curative Effect and Prognosis of SCLC

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Observation
  • (no location specified)
Sep 22, 2021

SCLC, Recurrent Trial in Seoul (Durvalumab+AZD2811 to SCLC patients)

Terminated
  • SCLC, Recurrent
  • Durvalumab+AZD2811 to SCLC patients
  • Seoul, Gangnam-gu, Korea, Republic of
    Samsung Medical Center
Feb 8, 2022

Small Cell Lung Cancer Extensive Stage Trial in France, Luxembourg (Carboplatin + Paclitaxel + Durvalumab)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Carboplatin + Paclitaxel + Durvalumab
  • Abbeville, France
  • +27 more
May 4, 2023

Small Cell Lung Cancer Limited Stage Trial (Prophylactic cranial irradiation, Thoracic radiotherapy, Chemotherapy)

Not yet recruiting
  • Small Cell Lung Cancer Limited Stage
  • Prophylactic cranial irradiation
  • +2 more
  • (no location specified)
Dec 14, 2022

SCLC, Extensive Stage Trial in Tianjin (DLL3-CAR-NK cells)

Recruiting
  • SCLC, Extensive Stage
  • DLL3-CAR-NK cells
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Aug 18, 2022

Limited Stage Small Cell Lung Cancer Trial in Guangzhou (Sugemalimab, Placebo)

Not yet recruiting
  • Limited Stage Small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 12, 2022

Immunotherapy, Second-line Treatment Trial in Guizhou (Cadonilimab)

Recruiting
  • Immunotherapy
  • Second-line Treatment
  • Guizhou, ZunYi, China
    The Second Affiliated Hospital of Zunyi Medical University
Jun 14, 2023

Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • Neuroendocrine Neoplasms
  • BI 764532
  • [89Zr]Zr-BI 764532
  • (no location specified)
Jul 31, 2023

Small-cell Lung Cancer Trial in Shanghai (thoracic radiotherapy)

Recruiting
  • Small-cell Lung Cancer
  • thoracic radiotherapy
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
Sep 21, 2022

Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • +3 more
  • (no location specified)
Dec 7, 2022

Small-cell Lung Cancer, SCLC, Small Cell Lung Cancer Limited Stage Trial in Baltimore (Hippocampal-sparing Prophylactic Cranial

Completed
Has Results
  • Small-cell Lung Cancer
  • +2 more
  • Hippocampal-sparing Prophylactic Cranial Irradiation
  • Baltimore, Maryland
  • +1 more
Sep 22, 2021

SCLC, Extensive Stage Trial in Zhengzhou (Utidelone, Placebo)

Recruiting
  • SCLC, Extensive Stage
  • Zhengzhou, Henan, China
    Henan Tumor Hospital
Mar 24, 2022

Small Cell Lung Cancer, SCLC, Extensive Stage Small Cell Lung Cancer Trial (Durvalumab, Monalizumab, Carboplatin or Cisplatin)

Not yet recruiting
  • Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Jun 5, 2023

Limited Stage Small Cell Lung Cancer Trial in Shanghai (Pamiparib)

Recruiting
  • Limited Stage Small Cell Lung Cancer
  • Shanghai, Shanghai, China
  • +1 more
Jul 29, 2022

Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Carboplatin, Etoposide)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • BI 764532
  • +5 more
  • (no location specified)
Oct 17, 2023

Small Cell Lung Cancer Trial in Shanghai (Blood sample collection)

Recruiting
  • Small Cell Lung Cancer
  • Blood sample collection
  • Shanghai, Shanghai, China
    Cancer hospital Fudan University
Jan 10, 2022

SCLC Trial in Shanghai (Carboplatin, Cisplatin, Etoposide)

Active, not recruiting
  • SCLC
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 18, 2022

Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, Ezabenlimab)

Not yet recruiting
  • Small Cell Lung Carcinoma (SCLC)
  • Neuroendocrine Neoplasms
  • (no location specified)
May 25, 2023

Small Cell Lung Cancer Trial in Worldwide (Tarlatamab, AMG 404)

Recruiting
  • Small Cell Lung Cancer
  • Chicago, Illinois
  • +13 more
Jul 27, 2022

Small Cell Lung Cancer and Other Solid Tumors Trial in Guangzhou (APG-1252)

Terminated
  • Small Cell Lung Cancer and Other Solid Tumors
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 24, 2021

Small Cell Lung Cancer Recurrent Trial in Goyang-si (Atezolizumab)

Recruiting
  • Small Cell Lung Cancer Recurrent
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
Apr 4, 2022